RYCKX vs. RYOIX
Compare and contrast key facts about Rydex S&P MidCap 400 Pure Growth Fund (RYCKX) and Rydex Biotechnology Fund (RYOIX).
RYCKX is managed by Rydex Funds. It was launched on Feb 20, 2004. RYOIX is managed by Rydex Funds. It was launched on Mar 31, 1998.
Performance
RYCKX vs. RYOIX - Performance Comparison
Loading graphics...
RYCKX vs. RYOIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYCKX Rydex S&P MidCap 400 Pure Growth Fund | 0.34% | 6.61% | 15.10% | 13.97% | -23.05% | 11.26% | 29.72% | 14.60% | -15.17% | 18.02% |
RYOIX Rydex Biotechnology Fund | -2.83% | 30.62% | -0.95% | 6.06% | -13.04% | 2.05% | 21.94% | 30.69% | -8.94% | 29.68% |
Returns By Period
In the year-to-date period, RYCKX achieves a 0.34% return, which is significantly higher than RYOIX's -2.83% return. Over the past 10 years, RYCKX has underperformed RYOIX with an annualized return of 6.45%, while RYOIX has yielded a comparatively higher 8.46% annualized return.
RYCKX
- 1D
- -1.99%
- 1M
- -9.85%
- YTD
- 0.34%
- 6M
- 2.73%
- 1Y
- 18.58%
- 3Y*
- 11.21%
- 5Y*
- 2.19%
- 10Y*
- 6.45%
RYOIX
- 1D
- 1.00%
- 1M
- -6.92%
- YTD
- -2.83%
- 6M
- 11.88%
- 1Y
- 28.65%
- 3Y*
- 10.88%
- 5Y*
- 3.74%
- 10Y*
- 8.46%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYCKX vs. RYOIX - Expense Ratio Comparison
RYCKX has a 2.26% expense ratio, which is higher than RYOIX's 1.36% expense ratio.
Return for Risk
RYCKX vs. RYOIX — Risk / Return Rank
RYCKX
RYOIX
RYCKX vs. RYOIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex S&P MidCap 400 Pure Growth Fund (RYCKX) and Rydex Biotechnology Fund (RYOIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYCKX | RYOIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.82 | 1.14 | -0.32 |
Sortino ratioReturn per unit of downside risk | 1.30 | 1.64 | -0.34 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.21 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.21 | 1.71 | -0.50 |
Martin ratioReturn relative to average drawdown | 5.17 | 6.79 | -1.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYCKX | RYOIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.82 | 1.14 | -0.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.10 | 0.18 | -0.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | 0.36 | -0.08 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.35 | -0.04 |
Correlation
The correlation between RYCKX and RYOIX is 0.70, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
RYCKX vs. RYOIX - Dividend Comparison
RYCKX has not paid dividends to shareholders, while RYOIX's dividend yield for the trailing twelve months is around 12.93%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYCKX Rydex S&P MidCap 400 Pure Growth Fund | 0.00% | 0.00% | 20.92% | 0.00% | 14.34% | 13.66% | 1.29% | 0.00% | 18.93% | 7.60% | 1.72% | 5.90% |
RYOIX Rydex Biotechnology Fund | 12.93% | 12.57% | 14.61% | 0.00% | 1.29% | 19.39% | 7.28% | 8.58% | 14.11% | 5.38% | 0.00% | 1.45% |
Drawdowns
RYCKX vs. RYOIX - Drawdown Comparison
The maximum RYCKX drawdown since its inception was -52.60%, smaller than the maximum RYOIX drawdown of -74.43%. Use the drawdown chart below to compare losses from any high point for RYCKX and RYOIX.
Loading graphics...
Drawdown Indicators
| RYCKX | RYOIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.60% | -74.43% | +21.83% |
Max Drawdown (1Y)Largest decline over 1 year | -13.33% | -12.10% | -1.23% |
Max Drawdown (5Y)Largest decline over 5 years | -35.98% | -33.66% | -2.32% |
Max Drawdown (10Y)Largest decline over 10 years | -44.75% | -33.66% | -11.09% |
Current DrawdownCurrent decline from peak | -10.50% | -7.52% | -2.98% |
Average DrawdownAverage peak-to-trough decline | -9.58% | -27.81% | +18.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.11% | 3.65% | -0.54% |
Volatility
RYCKX vs. RYOIX - Volatility Comparison
Rydex S&P MidCap 400 Pure Growth Fund (RYCKX) has a higher volatility of 7.64% compared to Rydex Biotechnology Fund (RYOIX) at 6.76%. This indicates that RYCKX's price experiences larger fluctuations and is considered to be riskier than RYOIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYCKX | RYOIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.64% | 6.76% | +0.88% |
Volatility (6M)Calculated over the trailing 6-month period | 13.60% | 13.23% | +0.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.74% | 22.95% | -0.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.65% | 21.08% | +1.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.96% | 23.33% | -0.37% |